Michal Maurin

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Rituximab when radiolabelled with (177)Lu or (90)Y has been investigated for the treatment of patients with Non-Hodgkin's Lymphoma. In this study, we optimized the preparation of antibody conjugates(More)
  • 1